Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CCRT vs RT Alone in Low-Risk Cervical Cancer
NCT00846508Phase 3Unknown
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Feb 2009
- Primary completion
- Jan 2012
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Cisplatin micelle injection (HA132) in Cervical Cancer (CC), sponsored by Chang Gung Memorial Hospital. Status: unknown.
02
Drugs
Cisplatin micelle injection (HA132)
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT00846508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00846508.